Advertisement
Advertisement

ANGO

ANGO logo

AngioDynamics, Inc.

12.34
USD
Sponsored
+0.41
+3.44%
Jun 09, 15:59 UTC -4
Closed
exchange

After-Market

12.36

+0.02
+0.12%

ANGO Earnings Reports

Positive Surprise Ratio

ANGO beat 29 of 41 last estimates.

71%

Next Report

Date of Next Report
Jul 13, 2026
Estimate for Q4 26 (Revenue/ EPS)
$82.01M
/
-$0.09
Implied change from Q3 26 (Revenue/ EPS)
+4.57%
/
-550.00%
Implied change from Q4 25 (Revenue/ EPS)
+2.31%
/
+200.00%

AngioDynamics, Inc. earnings per share and revenue

On Apr 02, 2026, ANGO reported earnings of 0.02 USD per share (EPS) for Q3 26, beating the estimate of -0.11 USD, resulting in a 117.83% surprise. Revenue reached 78.42 million, compared to an expected 78.30 million, with a 0.15% difference. The market reacted with a -13.65% price change (close before vs. close after earnings).
Looking ahead to Q4 26, 6 analysts forecast an EPS of -0.09 USD, with revenue projected to reach 82.01 million USD, implying an decrease of -550.00% EPS, and increase of 4.57% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Mesa Laboratories Inc
Report Date
May 27, 2026 For Q4 26
Estimate
$0.34
Actual
-$0.75
Surprise
-316.26%
logo
Autonomix Medical, Inc. Common Stock
Report Date
May 27, 2026 For Q4 26
Estimate
-$0.26
Actual
-$0.23
Surprise
+13.27%
FAQ
For Q3 2026, AngioDynamics, Inc. reported EPS of $0.02, beating estimates by 117.83%, and revenue of $78.42M, 0.15% above expectations.
The stock price moved down -13.65%, changed from $11.94 before the earnings release to $10.31 the day after.
The next earning report is scheduled for Jul 13, 2026.
Based on 6 analysts, AngioDynamics, Inc. is expected to report EPS of -$0.09 and revenue of $82.01M for Q4 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement